Description
Phase
Phase 4 - refines the treatment to become part of standard care.Inclusion and Exclusion Criteria
Please contact Valentina Rodina to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- University of Southern Califorina Keck School Of Medicine, Los Angeles, California, 90033
- Cedars-Sinai Medical Center, Los Angeles, California, 90048
- Inland Empire Liver Foundation, Rialto, California, 92377
- Loma Linda University Medical Center Transplantation Institute, Loma Linda, California, 92324
- UCSD Clinical & Translational Research Institute, Lajolla, California, 92037
- Southern California Liver Centers, Coronado, California, 92118
-
Arizona
- Banner Research, Phoenix, Arizona, 85016
- University Of Arizona Liver Research Institute, Tuscon, Arizona, 85724
-
Oregon
- Salix Site, Portland, Oregon, 97239
-
Colorado
- University of Colorado Denver, Aurora, Colorado, 80045
-
Washington
- Swedish Medical Center, Seattle, Washington, 98122
-
Texas
- Brook Army Medical Center, Fort Sam Houston, Texas, 78234
- The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, 75203
- The Methodist Hospital, Houston, Texas, 77030
- Salix Site, Galveston, Texas, 77555
-
Minnesota
- Mayo Clinic, Rochester, Minnesota, 55905
-
Missouri
- Washington University, St. Louis, Missouri, 63110
-
Louisiana
- Tulane Abdominal Transplant Research Office, New Orleans, Louisiana, 70112
-
Illinois
- Rush University Medical Center, Chicago, Illinois, 60612
- Northwestern University-Comprehensive Transplant Center, Chicago, Illinois, 60611
-
Georgia
- Piedmont Atlanta Hospital, Atlanta, Georgia, 30309
Powered by
SC CTSI